The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A multicenter phase II study of combination therapy with oral S-1 plus cisplatin in elderly patients with advanced gastric cancer.
 
Tetsuji Terazawa
No Relationships to Disclose
 
Satoru Iwasa
No Relationships to Disclose
 
Yusuke Sasaki
No Relationships to Disclose
 
Shunsuke Okazaki
No Relationships to Disclose
 
Masahiro Goto
No Relationships to Disclose
 
Yasushi Kojima
Research Funding - Bayer (Inst); Kyowa Hakko Kirin (Inst); NanoCarrier (Inst); Ono Pharmaceutical (Inst)
 
Atsushi Naganuma
No Relationships to Disclose
 
Kengo Nagashima
No Relationships to Disclose
 
Hidekazu Hirano
No Relationships to Disclose
 
Yoshitaka Honma
Speakers' Bureau - Nihonkayaku; Taiho Pharmaceutical
 
Atsuo Takashima
No Relationships to Disclose
 
Ken Kato
No Relationships to Disclose
 
Tetsuya Hamaguchi
Honoraria - Chugai Pharma; Merck Serono; Takeda; Yakult Honsha
Consulting or Advisory Role - NanoCarrier
Research Funding - Daiichi Sankyo (Inst); Dainippon Sumitomo Pharma (Inst); MSD (Inst); NanoCarrier (Inst); Ono Pharmaceutical (Inst); Sanofi (Inst); Taiho Pharmaceutical (Inst); Teijin Pharma (Inst)